László Mangel
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate Adenocarcinoma (NCT04586543) | László Mangel | 2020-05-18 |
Track László Mangel automatically
Every clearance here is in the API, with alerts when new ones post.